Abstract

HIV-1 envelope (Env) mimetics are candidate components of prophylactic vaccines and potential therapeutics. Here we use a synthetic V3-glycopeptide (“Man9-V3”) for structural studies of an HIV Env third variable loop (V3)-glycan directed, broadly neutralizing antibody (bnAb) lineage (“DH270”), to visualize the epitope on Env and to study how affinity maturation of the lineage proceeded. Unlike many previous V3 mimetics, Man9-V3 encompasses two key features of the V3 region recognized by V3-glycan bnAbs—the conserved GDIR motif and the N332 glycan. In our structure of an antibody fragment of a lineage member, DH270.6, in complex with the V3 glycopeptide, the conformation of the antibody-bound glycopeptide conforms closely to that of the corresponding segment in an intact HIV-1 Env trimer. An additional structure identifies roles for two critical mutations in the development of breadth. The results suggest a strategy for use of a V3 glycopeptide as a vaccine immunogen.

Details

Title
HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope
Author
Fera, Daniela 1   VIAFID ORCID Logo  ; Lee, Matthew S 1 ; Wiehe, Kevin 2 ; R Ryan Meyerhoff 3 ; Piai, Alessandro 4   VIAFID ORCID Logo  ; Bonsignori, Mattia 2 ; Aussedat, Baptiste 5 ; Walkowicz, William E 5 ; Ton, Therese 6 ; Zhou, Jeffrey O 7 ; Danishefsky, Samuel 5 ; Haynes, Barton F 2 ; Harrison, Stephen C 8 

 Laboratory of Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA 
 Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA 
 Duke Human Vaccine Institute, Durham, NC, USA; Department of Immunology, Duke University School of Medicine, Duke University Medical Center, Durham, NC, USA 
 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA 
 Department of Bioorganic Chemistry, Sloan Kettering Institute, New York, NY, USA 
 Department of Biology, Swarthmore College, Swarthmore, PA, USA 
 Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA, USA 
 Laboratory of Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA, USA 
Pages
1-11
Publication year
2018
Publication date
Mar 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2014497065
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.